Literature DB >> 33513803

Development of Self-Nanoemulsifying Drug Delivery Systems Containing 4-Allylpyrocatechol for Treatment of Oral Infections Caused by Candida albicans.

Siriporn Okonogi1,2, Pimpak Phumat3, Sakornrat Khongkhunthian2,4, Pisaisit Chaijareenont2,5, Thomas Rades6, Anette Müllertz6.   

Abstract

Clinical use of 4-Allylpyrocatechol (APC), a potential antifungal agent from Piper betle, is limited because of its low water solubility. The current study explores the development of the self-nanoemulsifying drug delivery system (SNEDDS) containing APC (APC-SNEDDS) to enhance APC solubility. Results demonstrated that excipient type and concentration played an important role in the solubility of APC in the obtained SNEEDS. SNEDDS, comprising 20% Miglyol 812N, 30% Maisine 35-1, 40% Kolliphor RH40, and 10% absolute ethanol, provided the highest loading capacity and significantly increased water solubility of APC. Oil-in-water nanoemulsions (NE) with droplet sizes of less than 40 nm and a narrow size distribution were obtained after dispersing this APC-SNEDDS in water. The droplets had a negative zeta potential between -10 and -20 mV. The release kinetics of APC from APC-SNEDDS followed the Higuchi model. The NE containing 1.6 mg APC/mL had effective activity against Candida albicans with dose-dependent killing kinetics and was nontoxic to normal cells. The antifungal potential was similar to that of 1 mg nystatin/mL. These findings suggest that APC-SNEDDS are a useful system to enhance the apparent water solubility of APC and are a promising system for clinical treatment of oral infection caused by C. albicans.

Entities:  

Keywords:  4-allylpyrocatechol; Candida albicans; SNEDDS; antifungal activity; oral infections; solubility enhancement

Year:  2021        PMID: 33513803     DOI: 10.3390/pharmaceutics13020167

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  4 in total

1.  Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies.

Authors:  Charul Rathore; Chetna Hemrajani; Abhishek Kumar Sharma; Piyush Kumar Gupta; Niraj Kumar Jha; Alaa A A Aljabali; Gaurav Gupta; Sachin Kumar Singh; Jen-Chang Yang; Ram Prakash Dwivedi; Kamal Dua; Dinesh Kumar Chellappan; Poonam Negi; Murtaza M Tambuwala
Journal:  Drug Deliv Transl Res       Date:  2022-07-13       Impact factor: 5.671

2.  Formulation and Evaluation of SNEDDS Loaded with Original Lipophenol for the Oral Route to Prevent Dry AMD and Stragardt's Disease.

Authors:  Maxime Vincent; Laurianne Simon; Philippe Brabet; Philippe Legrand; Christophe Dorandeu; Josephine Lai Kee Him; Thierry Durand; Céline Crauste; Sylvie Begu
Journal:  Pharmaceutics       Date:  2022-05-10       Impact factor: 6.525

Review 3.  Nanocarriers for delivery of siRNA as gene silencing mediator.

Authors:  Aideé Morales-Becerril; Liliana Aranda-Lara; Keila Isaac-Olivé; Blanca E Ocampo-García; Enrique Morales-Ávila
Journal:  EXCLI J       Date:  2022-08-01       Impact factor: 4.022

4.  The Binding of Alpinia galanga Oil and Its Nanoemulsion to Mammal GABAA Receptors Using Rat Cortical Membranes and an In Silico Modeling Platform.

Authors:  Nattakanwadee Khumpirapang; Krit Suknuntha; Pathomwat Wongrattanakamon; Supat Jiranusornkul; Songyot Anuchapreeda; Petrine Wellendorph; Anette Müllertz; Thomas Rades; Siriporn Okonogi
Journal:  Pharmaceutics       Date:  2022-03-16       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.